CT Dose in SPECT/CT and PET/CT

Introduction

In a SPECT/CT or PET/CT study, the CT scan is not a free anatomical bonus — it is a second radiation exposure that can equal or exceed the dose from the radiopharmaceutical, depending entirely on how the CT protocol is set. A program that treats the CT as an afterthought can easily double a patient's dose without a matching gain in diagnostic value.

Hybrid imaging earns its clinical value by fusing function with anatomy: the emission scan shows where tracer accumulates, and the CT places that uptake in anatomical context and corrects it for attenuation. ¹² But the CT in a hybrid scanner can be run three very different ways — as a minimal attenuation map, as a modest localization scan, or as a full diagnostic CT — and those three modes can differ in dose by more than an order of magnitude. ²³

This guide explains the three roles CT plays in hybrid imaging, the dose metrics that quantify the CT contribution, how the CT and internal doses combine into a total patient dose, and how to choose a CT protocol that answers the clinical question at the lowest reasonable dose. DRPS supports these programs through its PET/CT and nuclear medicine physics and CT physics testing services.

Topic Explanation

The three roles of CT in a hybrid scan

The single most important dose decision in hybrid imaging is choosing what the CT is for. There are three distinct roles, and each justifies a very different technique and dose: ²³

• Attenuation correction (AC) only. The CT produces a low-resolution attenuation map used to correct the emission data for photon absorption in the body. Image quality requirements are minimal, so very low tube current is sufficient and the dose is the smallest of the three.
• Anatomical localization. The CT is used to place tracer uptake anatomically — to say that a focus is in a rib rather than overlying soft tissue, for example. This needs more image quality than AC but far less than a diagnostic study, so a low-dose technique is appropriate.
• Diagnostic CT. The CT is a fully diagnostic examination in its own right, often with intravenous contrast, interpreted alongside the emission scan. It uses full diagnostic technique and carries the highest dose.

The same gantry can do all three. The error that drives unnecessary dose is acquiring a diagnostic-quality CT when only attenuation correction or localization was clinically required. ²³

Why the CT contribution matters

The total patient dose from a hybrid study is the sum of two independent contributions: the internal dose from the administered radiopharmaceutical and the external dose from the CT. ¹ Published analyses show that a diagnostic CT acquired as part of a combined SPECT/CT examination "contributes considerably to, and for some applications even dominates, the total patient exposure." ¹ For pediatric hybrid imaging, adding a SPECT/CT or PET/CT component increases the effective dose by a factor of roughly 1.5 to 2 for skeletal or whole-body studies compared with the emission scan alone. ⁵

Because the CT contribution is so protocol-dependent, it is also the most controllable part of the total dose — which is exactly why it deserves attention. For the complementary physics of why the CT map is needed in the first place, see our guide to PET/CT attenuation correction.

Key Technical Principles

CT dose metrics

The CT subsystem is characterized by the same dose indices used for standalone CT, reported on the scanner's dose page: ⁸

• Volume CT dose index, $\mathrm{CTD}{\mathrm{I}}_{\mathrm{vol}}$ (mGy) — a standardized measure of dose to a reference phantom for the selected technique; it reflects scanner output, not patient dose directly.
• Dose-length product, $\mathrm{DLP}$ (mGy·cm) — $\mathrm{CTD}{\mathrm{I}}_{\mathrm{vol}}$ multiplied by the scan length; it reflects the total energy imparted along the scan.

Effective dose from the CT can be estimated from DLP using a region-specific conversion factor $k$ (mSv·mGy⁻¹·cm⁻¹): ⁸

For an adult trunk at typical kilovoltage, $k$ is on the order of 0.015 mSv·mGy⁻¹·cm⁻¹; it is lower for the head and substantially higher for children. ⁸ A worked example for an adult body CT with a DLP of 300 mGy·cm gives:

Size-specific dose estimate

$\mathrm{CTD}{\mathrm{I}}_{\mathrm{vol}}$ is referenced to a fixed phantom, so it does not describe dose to a specific patient. The size-specific dose estimate (SSDE) corrects $\mathrm{CTD}{\mathrm{I}}_{\mathrm{vol}}$ for patient size using a conversion factor $f_{\mathrm{size}}$ based on an effective or water-equivalent diameter, per AAPM Report No. 204 and Report No. 220: ⁷¹⁰

Smaller patients — especially children — receive a higher absorbed dose than the phantom-referenced $\mathrm{CTD}{\mathrm{I}}_{\mathrm{vol}}$ implies, so SSDE is the more honest size-aware metric for optimization and for comparison with size-based reference levels. ⁷¹⁰

Combining CT and internal dose

The total effective dose from a hybrid study is the sum of the radiopharmaceutical and CT contributions:

The radiopharmaceutical term is estimated from administered activity and published dose coefficients such as those in ICRP Publication 128. ⁹ The split between the two terms varies by study: with an AC-only or localization CT, the radiopharmaceutical typically dominates; with a diagnostic CT, the CT often dominates. For adult F-18 FDG PET/CT and for many SPECT/CT studies, the two can be of comparable magnitude, which is why neither can be ignored in a dose-management program. ¹²⁶

Representative CT roles and dose

The exact doses depend on scanner, body region, patient size, and reconstruction, so each facility should characterize its own protocols rather than rely on generic values. A concrete published example: optimizing a lumbar-spine bone SPECT/CT protocol from 130 kVp / 70 mAs to 110 kVp / 40 mAs cut the mean DLP from about 267 mGy·cm to about 122 mGy·cm and the CT effective dose from about 4.0 mSv to about 1.8 mSv — while actually improving bony image quality. ⁴

Clinical Impact

The right CT protocol is the one matched to the clinical question, and getting that match right has a direct dose consequence for every patient.

For a bone SPECT/CT performed to localize an equivocal planar focus, a low-dose localization CT is usually sufficient; a full diagnostic CT of the region is rarely needed and roughly doubles or triples the CT dose for no added benefit in that task. ³⁴ For a staging FDG PET/CT where the CT must be read diagnostically with contrast, the diagnostic technique is justified — but it should then be optimized like any diagnostic CT, not left on a vendor default. ²

The pediatric case is the sharpest. Children are more radiosensitive, smaller, and often imaged repeatedly over a disease course, so both the administered activity and the CT technique must be reduced and weight-adjusted. ²³⁵ Analyses of pediatric PET/CT show that the PET component itself can contribute more organ dose than the CT in several organs, so dose reduction must address both the radiopharmaceutical and the CT, not the CT alone. ⁶ For the emission-side half of that optimization — how administered activity maps to internal dose — see our guide to radiopharmaceutical dosimetry and ICRP 128.

Finally, the CT dose interacts with quantification. The CT provides the attenuation map that underlies quantitative SUV and activity concentration, so protocol and registration quality affect not only dose but also the numbers clinicians act on — a link explored in quantitative SPECT/CT calibration.

Practical Optimization Tips

A practical CT dose-management workflow for a hybrid program follows a short sequence.

1. Decide the CT's role before the scan

Write protocols explicitly labeled by role — attenuation correction, localization, or diagnostic — so technologists select the lowest-dose option that satisfies the clinical question.

2. Use the lowest technique for the role

• For AC-only, use the vendor's lowest-dose attenuation-map technique.
• For localization, reduce tube current and voltage relative to diagnostic settings and rely on registration, not fine detail.
• For diagnostic CT, optimize kVp and mAs for the body region rather than accepting defaults.

3. Turn on the dose-reduction tools

Enable automatic tube current modulation, use iterative or deep-learning reconstruction where available to permit lower tube current, and select an appropriate kVp — lower kVp often reduces dose while preserving the contrast needed for localization. The same logic that governs standalone CT applies here; see CTDIvol and DLP dose metrics.

4. Restrict the scan length

Scan only the region required. Over-ranging and generous margins add DLP directly, because DLP scales with scan length.

5. Adjust for patient size and age

Use SSDE and size- or weight-based technique charts, and apply dedicated pediatric protocols. A one-size technique over-doses children and under-penetrates large adults.

6. Record, review, and benchmark

Capture $\mathrm{CTD}{\mathrm{I}}_{\mathrm{vol}}$ and DLP from every exam, review them against diagnostic reference levels for each CT role, and have a qualified medical physicist review protocols periodically and after any scanner or software change.

Common pitfalls to avoid

• Acquiring a diagnostic CT when only localization or AC is needed. This is the single largest avoidable dose source in hybrid imaging.
• Leaving vendor default protocols unoptimized. Defaults are starting points, not optimized techniques.
• Ignoring patient size. $\mathrm{CTD}{\mathrm{I}}_{\mathrm{vol}}$ alone misstates dose to small and pediatric patients; use SSDE.
• Optimizing only the CT or only the radiopharmaceutical. Total dose is the sum; both terms matter.
• Scanning beyond the region of interest. Extra scan length is extra DLP.

Regulatory Considerations

There is no regulatory patient dose limit for a justified medical examination, but the CT in a hybrid scanner is subject to the same justification and optimization expectations as any CT scanner. The governing principles are justification (the exam, and each CT role within it, must be warranted) and optimization (dose kept as low as reasonably achievable for the diagnostic task). ⁸

Key frameworks for a hybrid-imaging dose program:

• Justification and optimization of CT dose — the principles and practical methods for managing multi-detector CT dose are set out in ICRP Publication 102. ⁸
• Radiopharmaceutical dose coefficients — ICRP Publication 128 provides the dose estimates used for the internal component of the total. ⁹
• Size-aware dose metrics — AAPM Reports No. 204 and No. 220 define SSDE and the water-equivalent diameter used for patient-size correction. ⁷¹⁰
• Medical use of the radiopharmaceutical — the emission side is regulated as medical use of byproduct material under 10 CFR Part 35 (or the equivalent Agreement State program); the CT subsystem is regulated as a radiation-producing machine under state radiation-control rules. ¹
• Diagnostic reference levels (DRLs) — facilities should compare their CT dose indices for each CT role against applicable DRLs and investigate values that are persistently high, as discussed in our guide to nuclear medicine diagnostic reference levels.

Documenting protocol intent, CT dose indices, size-based technique charts, and periodic physicist review is what makes a hybrid-imaging dose program defensible during accreditation and inspection. The ACR–AAPM CT technical standard frames the medical physicist's role in this review. ¹¹

Frequently Asked Questions (FAQs)

How much does the CT scan add to dose in SPECT/CT or PET/CT?

It depends entirely on the CT protocol. An attenuation-correction-only CT adds a small fraction of a millisievert, a localization CT adds roughly 1 to a few millisieverts, and a fully diagnostic CT can add 5 to 15 millisieverts or more. For many hybrid studies the CT doubles the patient's effective dose compared with the emission scan alone.

What is the difference between an attenuation-correction CT and a diagnostic CT?

An attenuation-correction CT uses very low tube current to produce an attenuation map and needs only coarse image quality, so its dose is minimal. A localization CT uses modest technique for anatomical registration. A diagnostic CT uses full diagnostic technique, often with contrast, to be interpreted on its own, and carries the highest dose.

What CT dose metrics should a nuclear medicine program track?

Track CTDIvol in milligray and DLP in milligray-centimeter from the scanner's dose report, use DLP with a region-specific k factor to estimate effective dose, and use the size-specific dose estimate (SSDE) to account for patient size. Compare values against diagnostic reference levels for the specific CT role.

Does the CT dose or the radiopharmaceutical dose dominate the total?

Either can dominate. With a low-dose attenuation-correction or localization CT, the radiopharmaceutical usually dominates the effective dose. With a fully diagnostic CT, the CT often dominates. The total patient dose is the sum of the internal dose from the radiopharmaceutical and the external dose from the CT.

How can CT dose in hybrid imaging be reduced without losing the needed information?

Match the CT protocol to its role, use the lowest tube current and voltage consistent with that role, enable tube current modulation and iterative reconstruction, restrict the scan length to the region of interest, and adjust technique for patient size and for children. Do not acquire a diagnostic-quality CT when only attenuation correction or localization is needed.

Are there separate dose limits for the CT part of a hybrid scan?

There are no regulatory patient dose limits for a justified medical exam, but the CT subsystem is governed by the same optimization and justification principles as standalone CT. Facilities should apply diagnostic reference levels, record CT dose indices, and have a qualified medical physicist review protocols.

Key Takeaways

• The CT's role sets its dose. Attenuation correction, localization, and diagnostic CT differ in dose by more than an order of magnitude; choose the lowest role that answers the question.
• The CT can equal or exceed the radiopharmaceutical dose. Total patient dose is the sum of the internal and CT contributions, and a diagnostic CT often dominates.
• Track CTDIvol, DLP, and SSDE. Use DLP with a region-specific k factor for effective dose and SSDE for patient-size-aware dose.
• Optimization tools work. Tube current modulation, iterative reconstruction, appropriate kVp, and restricted scan length reduce CT dose without sacrificing the needed information.
• Children need both sides optimized. Reduce administered activity and CT technique together, and use SSDE and weight-based charts.
• Document and benchmark. Compare against diagnostic reference levels and have a qualified medical physicist review hybrid CT protocols.

Conclusion

The CT in a hybrid scanner is a powerful tool and a real radiation exposure. Treating it with the same discipline applied to standalone CT — deciding its role before the scan, matching technique to that role, using the available dose-reduction tools, correcting for patient size, and benchmarking against reference levels — lets a nuclear medicine program capture the full diagnostic value of SPECT/CT and PET/CT while keeping the CT contribution to total patient dose as low as reasonably achievable. The emission scan and the CT each carry dose; a good program optimizes both.

How DRPS Can Help

Diagnostic Radiation Physics Services helps nuclear medicine and PET/CT facilities build defensible, optimized hybrid-imaging dose programs. Our support includes PET/CT and nuclear medicine physics, CT physics testing, CT protocol review by CT role, SSDE and dose-index benchmarking, pediatric protocol development, and medical physicist consulting prepared by board-certified medical physicists.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware. To review your hybrid-imaging CT protocols, contact DRPS.

Related Resources

• PET/CT attenuation correction
• Quantitative SPECT/CT calibration
• PET/CT NEMA NU-2 performance testing
• PET/CT daily QC and calibration
• CTDIvol and DLP dose metrics
• PET/CT and nuclear medicine physics
• CT physics testing
• Medical physicist consulting

References

1. Brix G, Nekolla EA, Borowski M, Noßke D. Radiation risk and protection of patients in clinical SPECT/CT. Eur J Nucl Med Mol Imaging. 2013;41(Suppl 1):S125-S136. doi:10.1007/s00259-013-2543-3. PubMed
2. Gelfand MJ, Lemen LC. PET/CT and SPECT/CT dosimetry in children: the challenge to the pediatric imager. Semin Nucl Med. 2007;37(5):391-398. doi:10.1053/j.semnuclmed.2007.05.002. PubMed
3. Gelfand MJ. Dose reduction in pediatric hybrid and planar imaging. Q J Nucl Med Mol Imaging. 2010;54(4):379-388. PubMed
4. Gupta SK, Trethewey S, Brooker B, et al. Radionuclide bone scan SPECT-CT: lowering the dose of CT significantly reduces radiation dose without impacting CT image quality. Am J Nucl Med Mol Imaging. 2017;7(2):63-73. PubMed
5. Zvonova I, Chipiga L, Balonov M, Ermolina E. Nuclear medicine examinations of children in Russia. Radiat Prot Dosimetry. 2015;165(1-4):216-219. doi:10.1093/rpd/ncv101. PubMed
6. Jia H, Xue M, Li X, Zhuang M, Xie T. Patient-specific radiation dose for Chinese pediatric patients undergoing whole-body PET/CT examinations. Phys Med Biol. 2024;69(12):125012. doi:10.1088/1361-6560/ad4f46. PubMed
7. Boone JM, Strauss KJ, Cody DD, et al. Size-Specific Dose Estimates (SSDE) in Pediatric and Adult Body CT Examinations. AAPM Report No. 204. College Park, MD: American Association of Physicists in Medicine; 2011. aapm.org
8. International Commission on Radiological Protection. ICRP Publication 102: Managing Patient Dose in Multi-Detector Computed Tomography (MDCT). Ann ICRP. 2007;37(1). icrp.org
9. International Commission on Radiological Protection. ICRP Publication 128: Radiation Dose to Patients from Radiopharmaceuticals. Ann ICRP. 2015;44(2S). icrp.org
10. American Association of Physicists in Medicine. Use of Water Equivalent Diameter for Calculating Patient Size and Size-Specific Dose Estimates (SSDE) in CT. AAPM Report No. 220. College Park, MD: AAPM; 2014. aapm.org
11. American College of Radiology. ACR–AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of Computed Tomography (CT) Equipment. Reston, VA: ACR. acr.org